C075-0256 Screening compound: N-{3-[benzyl(ethyl)amino]propyl}-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

C075-0256 Screening compound: N-{3-[benzyl(ethyl)amino]propyl}-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide
C075-0256 Screening compound: N-{3-[benzyl(ethyl)amino]propyl}-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C075-0256
N-{3-[benzyl(ethyl)amino]propyl}-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C075-0256

Molecular Formula

C30H33N5O4 (C30 H33 N5 O4)

Compound Name

N-{3-[benzyl(ethyl)amino]propyl}-2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

IUPAC name

N-{3-[benzyl(ethyl)amino]propyl}-2-{[3-(4-methoxyphenyl)-4-oxo-34-dihydrophthalazin-1-yl]formamido}acetamide

SMILES

CCN(CCCNC(CNC(C(c1c2cccc1)=NN(c(cc1)ccc1OC)C2=O)=O)=O)Cc1ccccc1

InChI

InChI=1S/C30H33N5O4/c1-3-34(21-22-10-5-4-6-11-22)19-9-18-31-27(36)20-32-29(37)28-25-12-7-8-13-26(25)30(38)35(33-28)23-14-16-24(39-2)17-15-23/h4-8,10-17H,3,9,18-21H2,1-2H3,(H,31,36)(H,32,37)

InChI Key

BGLKCFWKCXPGSR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14717778

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

527.62

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.284

Distribution Coefficient, logD

1.637

Water Solubility, LogSw

-3.70

Polar Surface Area

86.004

Acid Dissociation Constant (pKa)

12.09

Base Dissociation Constant (pKb)

9.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.70

C075-0256 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Others

References: we are preparing a list of scientific research reports with C075-0256 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C075-0256?
Check Price and Availability of C075-0256, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C075-0256 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C075-0256
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C075-0256
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C075-0256 available by request